Randall J. Bateman

Also affiliated with Biomedical Research Networking Center on Neurodegenerative Diseases

MedicineNeuroscienceBiochemistry, Genetics and Molecular BiologyEnvironmental Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

13.0Author DataRank

Indexed papers

10in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 10 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques

Neurology(2021)10.1212/wnl.0000000000013211

Top 4%

4.9DataRank

Top 4%193 citations

Suzanne E. Schindler, James G. Bollinger, Vitaliy Ovod, Kwasi G. Mawuenyega, Michael W. Weiner +10 more

Papers

Driven by 157 papers — median percentile 78. Top paper: “Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques”.

Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques

Neurology(2021)10.1212/wnl.0000000000013211

Top 4%

4.9DataRank

Top 4%193 citations

Suzanne E. Schindler, James G. Bollinger, Vitaliy Ovod, Kwasi G. Mawuenyega, Michael W. Weiner +10 more

Detection of β-amyloid positivity in Alzheimer’s Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers

Brain Communications(2021)10.1093/braincomms/fcab008

N/A

3.0DataRank · unranked

84 citations

Dallas P. Veitch, Paul Aisen, Clifford R. Jack, William J. Jagust, Ronald C. Petersen +11 more

Sequence of Alzheimer disease biomarker changes in cognitively normal adults

Neurology(2020)10.1212/wnl.0000000000010747

Top 12%

1.8DataRank

Top 12%60 citations

Folasade Agboola, Elizabeth Grant, Colin L. Masters, Marilyn Albert, Sterling C. Johnson +18 more

Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity

Alzheimer s & Dementia(2022)10.1002/alz.12697

Top 13%

1.6DataRank

Top 13%61 citations

Randall J. Bateman, Leslie M. Shaw, Henrik Zetterberg, Anthony W. Bannon, Wesley A. Horton +20 more

Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease

NeuroImage(2022)10.1016/j.neuroimage.2022.119228

N/A

1.6DataRank · unranked

69 citations

Patrick H. Luckett, Brian A. Gordon, Tammie L.S. Benzinger, Suzanne E. Schindler, Anne M. Fagan +87 more

Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer’s disease

Science Translational Medicine(2023)10.1126/scitranslmed.abq5923

N/A

1.5DataRank · unranked

91 citations

Chengran Yang, Joanne Norton, Matt Johnson, Anne M. Fagan, Randall J. Bateman +21 more

Autosomal dominant and sporadic late onset Alzheimer's disease share a commonin vivopathophysiology

Brain(2022)10.1093/brain/awac181

N/A

1.4DataRank · unranked

62 citations

Michael W. Weiner, Johannes Levin, Laurel Beckett, Dean W. Coble, Naomi Saito +40 more

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial

The Lancet Neurology(2025)10.1016/s1474-4422(25)00024-9

N/A

1.2DataRank · unranked

41 citations

Yan Li, Eric McDade, Jorge J. Llibre‐Guerra, David B. Clifford, Alireza Atri +62 more

Association ofBDNFVal66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease

JAMA Neurology(2022)10.1001/jamaneurol.2021.5181

N/A

1.2DataRank · unranked

37 citations

Paul Maruff, Nicolas R. Barthélemy, Alison Goate, Jason Hassenstab, Chihiro Sato +87 more

Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease

Neurology(2021)10.1212/wnl.0000000000011542

N/A

1.0DataRank · unranked

28 citations

Guoqiao Wang, Kejal Kantarci, Clifford R. Jack, Eric McDade, Jason Hassenstab +52 more

Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN)

Nature Neuroscience(2023)10.1038/s41593-023-01359-8

Top 20%

1.0DataRank

Top 20%47 citations

Brian A. Gordon, Russ C. Hornbeck, Aylin Dincer, Shaney Flores, Sarah Keefe +59 more

Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease

JAMA Neurology(2024)10.1001/jamaneurol.2024.0991

N/A

1.0DataRank · unranked

29 citations

Haiyan Liu, Guoqiao Wang, Xinyu Shi, Tobias Bittner, Marzia A. Scelsi +94 more

Progressive White Matter Injury in Preclinical Dutch Cerebral Amyloid Angiopathy

Annals of Neurology(2022)10.1002/ana.26429

N/A

0.921DataRank · unranked

20 citations

Wai‐Ying Wendy Yau, Stephanie A. Schultz, Aaron P. Schultz, Matthew R. Scott, Maged Goubran +17 more

Longitudinal Relationships of White Matter Hyperintensities and Alzheimer Disease Biomarkers Across the Adult Life Span

Neurology(2023)10.1212/wnl.0000000000207378

Top 22%

0.921DataRank

Top 22%30 citations

Yinjiao Ma, Folasade Agboola, Elizabeth Grant, John C. Morris, Eric McDade +13 more

Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease

Brain Connectivity(2021)10.1089/brain.2020.0808

Top 23%

0.874DataRank

Top 23%27 citations

Jeremy F. Strain, Aaron Tanenbaum, Anne M. Fagan, Jason Hassenstab, Eric McDade +27 more

Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease

Acta Neuropathologica(2021)10.1007/s00401-021-02342-y

N/A

0.856DataRank · unranked

28 citations

Nelly Joseph‐Mathurin, Namita Sinha, Aihong Zhou, Yan Li, Karl A. Friedrichsen +26 more

Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease

European Journal of Nuclear Medicine and Molecular Imaging(2023)10.1007/s00259-023-06209-0

N/A

0.765DataRank · unranked

24 citations

Austin McCullough, Brian A. Gordon, Nelly Joseph‐Mathurin, Shaney Flores, Nicole S. McKay +48 more

Regional age-related atrophy after screening for preclinical alzheimer disease

Neurobiology of Aging(2021)10.1016/j.neurobiolaging.2021.09.010

N/A

0.703DataRank · unranked

24 citations

Pamela LaMontagne, Matthew F. Glasser, Randall J. Bateman, David M. Holtzman, Igor Yakushev +10 more

Genetic and multi-omic resources for Alzheimer disease and related dementia from the Knight Alzheimer Disease Research Center

Scientific Data(2024)10.1038/s41597-024-03485-9

Top 29%

0.695DataRank

Top 29%33 citations

Menghan Liu, Aleksandra Beric, Matt Johnson, Arda Cetin, Maulik Patel +38 more

A peptide-centric quantitative proteomics dataset for the phenotypic assessment of Alzheimer’s disease

Scientific Data(2023)10.1038/s41597-023-02057-7

Top 31%

0.652DataRank

Top 31%25 citations

Jea Park, Deanna L. Plubell, Brian C. Searle, C. Dirk Keene, Eric B. Larson +11 more

TNFR-1 and GDF-15 Are Associated With Plasma Neurofilament Light Chain and Progranulin Among Community-Dwelling Older Adults: A Secondary Analysis of the MAPT Study

The Journals of Gerontology Series A(2022)10.1093/gerona/glac244

N/A

0.560DataRank · unranked

14 citations

Philipe de Souto Barreto, Sophie Guyonnet, John E. Morley, Andrew D. Nguyen, Geetika Aggarwal +89 more

Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer’s disease

Neurotherapeutics(2025)10.1016/j.neurot.2025.e00591

N/A

0.548DataRank · unranked

13 citations

Juan Pablo Palavicini, Justin Melendez, Nicolas R. Barthélemy, Yingxin He, Tiffany F. Kautz +22 more

Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal‐dominant Alzheimer's disease

Aging Cell(2023)10.1111/acel.13871

N/A

0.426DataRank · unranked

11 citations

Zahra Shirzadi, Aaron P. Schultz, Lei Liu, Colleen Fitzpatrick, Eric McDade +42 more

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer’s disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial

medRxiv(2024)10.1101/2024.10.29.24316289

N/A

0.351DataRank · unranked

6 citations

Yan Li, Eric McDade, Jorge J. Llibre‐Guerra, David B. Clifford, Alireza Atri +63 more

15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIAN

medRxiv(2024)10.1101/2024.08.08.24311689

Top 52%

0.331DataRank

Top 52%7 citations

Eric McDade, Jorge J. Llibre‐Guerra, Johannes Levin, Richard J. Perrin, Laura Ibáñez +37 more

T1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer disease

Human Brain Mapping(2023)10.1002/hbm.26514

N/A

0.257DataRank · unranked

4 citations

Matthew R. Brier, Brian A. Gordon, Nicole S. McKay, Shaney Flores, Sarah Keefe +29 more

Distribution of big tau isoforms in the human central and peripheral nervous system

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.15.676127

Top 78%

0.104DataRank

Top 78%1 citations

Nicolas R. Barthélemy, Kanta Horie, Cindy V. Ly, Kaleigh F. Roberts, Srinivas Koutarapu +9 more

Different rates of cognitive decline in autosomal dominant and late‐onset Alzheimer disease

Alzheimer s & Dementia(2021)10.1002/alz.12505

N/A

0DataRank · unranked

8 citations

Johannes Levin, Randall J. Bateman, Jason Hassenstab, Ricardo Allegri, Sarah Berman +25 more

Recapitulation of Endogenous 4R Tau Expression and Formation of Insoluble Tau in Directly Reprogrammed Human Neurons

SSRN Electronic Journal(2021)10.2139/ssrn.3899434

N/A

0DataRank · unranked

6 citations

Chihiro Sato, Elena Ficulle, Anan Yu, Kanta Horie, Nicolas R. Barthélemy +9 more

Multi-tissue proteomics identifies molecular signatures for sporadic and genetically defined Alzheimer disease cases

Research Square(2021)10.21203/rs.3.rs-923492/v1

N/A

0DataRank · unranked

4 citations

Yun Ju Sung, Chengran Yang, Fengxian Wang, Adam Suhy, Joanne Norton +14 more

Spontaneous Isomerization of Asp387 in Tau is Diagnostic for Alzheimer’s Disease: An Endogenous Indicator of Reduced Autophagic Flux

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.21.440819

N/A

0DataRank · unranked

0 citations

Lilian R. Heil, Gennifer E. Merrihew, Jasmeer P. Chhatwal, Martin R. Farlow, Catriona McLean +10 more

Circular RNA detection identifies circPSEN1 alterations in brain specific to Autosomal Dominant Alzheimer Disease

medRxiv(2021)10.1101/2021.10.29.21265617

N/A

0DataRank · unranked

0 citations

Abdallah M. Eteleeb, Ciyang Wang, María Victoria Fernández, John Budde, Kristy Bergmann +18 more

Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring

Nature Medicine(2022)10.1038/s41591-022-02074-w

N/A

0DataRank · unranked

437 citations

Shorena Janelidze, Niklas Mattsson, Alexa Pichet Binette, Olof Strandberg, Wagner S. Brum +18 more

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

JAMA Neurology(2022)10.1001/jamaneurol.2021.5216

N/A

0DataRank · unranked

292 citations

Olin Janssen, Betty M. Tijms, Stephanie J. B. Vos, Rik Ossenkoppele, Pieter Jelle Visser +95 more

Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance

Alzheimer s & Dementia(2022)10.1002/alz.12787

N/A

0DataRank · unranked

222 citations

Shorena Janelidze, Nicholas Cullen, Jeffrey L. Dage, Randall J. Bateman, Henrik Zetterberg +5 more

Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light

Neurology(2022)10.1212/wnl.0000000000200358

N/A

0DataRank · unranked

148 citations

Thomas K. Karikari, Nicholas J. Ashton, Rachel L. Henson, Kevin E. Yarasheski, Tim West +16 more

CSF tau microtubule-binding region identifies pathological changes in primary tauopathies

Nature Medicine(2022)10.1038/s41591-022-02075-9

N/A

0DataRank · unranked

94 citations

Nicolas R. Barthélemy, Salvatore Spina, Lawren VandeVrede, Yingxin He, Ross W. Paterson +17 more

Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ‐PET, neurodegeneration, and cognition

Alzheimer s & Dementia(2022)10.1002/alz.12879

N/A

0DataRank · unranked

84 citations

Lisa Vermunt, Brian A. Gordon, Steve Pedrini, Lynn Boonkamp, Nicola J. Armstrong +33 more

Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study

The Lancet Neurology(2022)10.1016/s1474-4422(21)00375-6

N/A

0DataRank · unranked

76 citations

Stephanie A. Schultz, Eric McDade, Aaron P. Schultz, Lei Liu, Bernard Hanseeuw +34 more

Comparative Analysis of Alzheimer’s Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach

Journal of Alzheimer s Disease(2022)10.3233/jad-220399

N/A

0DataRank · unranked

70 citations

Duber Gomez‐Fonseca, Lihua Wang, Anh Do, Daniel Western, Ignacio Álvarez +21 more

Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neurons

Cell stem cell(2022)10.1016/j.stem.2022.04.018

N/A

0DataRank · unranked

64 citations

Chihiro Sato, Elena Ficulle, Anan Yu, Kanta Horie, Ji‐Sun Kwon +11 more

Importance of CSF-based Aβ clearance with age in humans increases with declining efficacy of blood-brain barrier/proteolytic pathways

Communications Biology(2022)10.1038/s42003-022-03037-0

N/A

0DataRank · unranked

56 citations

Bruce W. Patterson, Brendan P. Lucey, Tammie L.S. Benzinger, Randall J. Bateman, Donald L. Elbert

Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study

The Lancet Neurology(2022)10.1016/s1474-4422(22)00408-2

N/A

0DataRank · unranked

56 citations

Brian A. Gordon, Julie K. Wisch, Shaney Flores, Rachel L. Henson, Omar H. Butt +95 more

A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer’s disease

Brain Communications(2022)10.1093/braincomms/fcac045

N/A

0DataRank · unranked

55 citations

Yingxin He, Nicolas R. Barthélemy, Hong Jiang, Yan Li, Ethan Park +5 more

Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan

Brain(2022)10.1093/brain/awac238

N/A

0DataRank · unranked

46 citations

Folasade Agboola, Elizabeth Grant, John C. Morris, Colin L. Masters, Marilyn Albert +19 more

Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease

Annals of Neurology(2022)10.1002/ana.26511

N/A

0DataRank · unranked

44 citations

Jorge J. Llibre‐Guerra, Yan Li, Austin McCullough, Carsten Hofmann, Jakub Wojtowicz +49 more

Using Alzheimer's disease blood tests to accelerate clinical trial enrollment

Alzheimer s & Dementia(2022)10.1002/alz.12754

N/A

0DataRank · unranked

39 citations

Yan Li, Melody Li, Alyssa Despotis, Ethan Park, Liberty Vittert +8 more

Metabolomic and lipidomic signatures in autosomal dominant and late‐onset Alzheimer's disease brains

Alzheimer s & Dementia(2022)10.1002/alz.12800

N/A

0DataRank · unranked

36 citations

María Victoria Fernández, Ciyang Wang, John Budde, Kristy Bergmann, Abdallah M. Eteleeb +24 more

Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer disease

Alzheimer s & Dementia(2022)10.1002/alz.12624

N/A

0DataRank · unranked

42 citations

Jonathan Vöglein, Yakeel T. Quiroz, Randall J. Bateman, Valentina Ghisays, Francisco Lopera +5 more

Circular RNA detection identifies circPSEN1 alterations in brain specific to autosomal dominant Alzheimer's disease

Acta Neuropathologica Communications(2022)10.1186/s40478-022-01328-5

N/A

0DataRank · unranked

32 citations

Abdallah M. Eteleeb, Ciyang Wang, María Victoria Fernández, John Budde, Kristy Bergmann +18 more

The Future of AD Clinical Trials with the Advent of Anti-Amyloid Therapies: An CTAD Task Force Report

The Journal of Prevention of Alzheimer s Disease(2022)10.14283/jpad.2022.48

N/A

0DataRank · unranked

28 citations

Randall J. Bateman, J. Touchon, Marwan Sabbagh, Jeffrey L. Cummings, Julien Delrieu

To BYOD or not: Are device latencies important for bring-your-own-device (BYOD) smartphone cognitive testing?

Behavior Research Methods(2022)10.3758/s13428-022-01925-1

N/A

0DataRank · unranked

24 citations

Benjamin Wang, Andrew J. Aschenbrenner, Martin J. Sliwinski, Scott T. Yabiku, Nelson Roque +5 more

Covariance-based vs. correlation-based functional connectivity dissociates healthy aging from Alzheimer disease

NeuroImage(2022)10.1016/j.neuroimage.2022.119511

N/A

0DataRank · unranked

22 citations

Matthew R. Brier, Aaron Tanenbaum, Brian A. Gordon, John E. McCarthy, Aylin Dincer +17 more

Proportional constrained longitudinal data analysis models for clinical trials in sporadic Alzheimer's disease

Alzheimer s & Dementia Translational Research & Clinical Interventions(2022)10.1002/trc2.12286

N/A

0DataRank · unranked

20 citations

Lei Liu, Yan Li, Andrew J. Aschenbrenner, Randall J. Bateman, Paul Delmar +5 more

Therapeutic Targets for Alzheimer's Disease: Amyloid Vs. Non-Amyloid. Where Does Consensus Lie Today? An CTAD Task Force Report

The Journal of Prevention of Alzheimer s Disease(2022)10.14283/jpad.2022.29

N/A

0DataRank · unranked

13 citations

Adam L. Boxer, D. S. Knopman, Jonathan T. Sims, Rachelle S. Doody, P. Aisen +4 more

Pattern and implications of neurological examination findings in autosomal dominant Alzheimer disease

Alzheimer s & Dementia(2022)10.1002/alz.12684

N/A

0DataRank · unranked

9 citations

Nicolai Franzmeier, John C. Morris, Marianne Dieterich, Eric McDade, Mikael Simons +39 more

Herpes simplex virus and rates of cognitive decline or whole brain atrophy in the Dominantly Inherited Alzheimer Network

Annals of Clinical and Translational Neurology(2022)10.1002/acn3.51669

N/A

0DataRank · unranked

11 citations

Sharon L Cadogan, Jennifer M. Nicholas, Judith Breuer, Divya Shah, Neil Pearce +17 more

Biomarker clustering in autosomal dominant Alzheimer's disease

Alzheimer s & Dementia(2022)10.1002/alz.12661

N/A

0DataRank · unranked

10 citations

Charlie Chen, Brian A. Gordon, Julie K. Wisch, Sarah Berman, Jasmeer P. Chhatwal +38 more

The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method

Scientific Reports(2022)10.1038/s41598-022-18869-3

N/A

0DataRank · unranked

3 citations

Randall J. Bateman, Monika Łysakowska, Ammaarah Khatri, Dinorah Jean-Gilles, Matthew Kennedy +2 more

Neuroimaging within the Dominantly Inherited Alzheimer’s Network (DIAN): PET and MRI

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.25.485799

N/A

0DataRank · unranked

7 citations

Brian A. Gordon, Russ C. Hornbeck, Clifford R. Jack, Robert A. Koeppe, Shaney Flores +53 more

To BYOD or Not: Are Device Latencies Important for Bring Your Own Device (BYOD) Smartphone Cognitive Testing?

PsyArXiv (OSF Preprints)(2022)10.31234/osf.io/y6kp7

N/A

0DataRank · unranked

2 citations

Benjamin Wang, Andrew J. Aschenbrenner, Martin J. Sliwinski, Scott T. Yabiku, Nelson Roque +4 more

Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.25.505251

N/A

0DataRank · unranked

2 citations

Brian A. Gordon, Patrick H. Luckett, Tammie L.S. Benzinger, Carlos Cruchaga, Anne M. Fagan +13 more

CSF tau phosphorylation at T217 and T205 are improved biomarkers of amyloid and tau pathology in Alzheimer disease

Research Square(2022)10.21203/rs.3.rs-2175929/v1

N/A

0DataRank · unranked

2 citations

Benjamin Saef, Yan Li, Brian A. Gordon, Yingxin He, Kanta Horie +14 more

A Method For The Quantitation Of The Metabolism Of Soluble Amyloid Precursor Protein Isoforms Using A Stable Isotope Labeling Kinetics Approach Paired With Tandem Mass Spectrometry

Research Square(2022)10.21203/rs.3.rs-1321675/v1

N/A

0DataRank · unranked

0 citations

Randall J. Bateman, Monika Łysakowska, Ammaarah Khatri, Dinorah Jean-Gilles, Matthew Kennedy +2 more

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease

Nature Medicine(2023)10.1038/s41591-023-02476-4

N/A

0DataRank · unranked

179 citations

Shijia Bian, Rafi U. Haque, Kathleen Carter, Caroline M Watson, Brian A. Gordon +93 more

CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease

Nature Aging(2023)10.1038/s43587-023-00380-7

N/A

0DataRank · unranked

153 citations

Benjamin Saef, Yan Li, Brian A. Gordon, Yingxin He, Kanta Horie +14 more

Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease

Acta Neuropathologica Communications(2023)10.1186/s40478-023-01563-4

N/A

0DataRank · unranked

58 citations

Derek B. Archer, Priyanka Gorijala, Daniel Western, Jigyasha Timsina, María Victoria Fernández +49 more

Suvorexant Acutely Decreases Tau Phosphorylation and Aβ in the Human CNS

Annals of Neurology(2023)10.1002/ana.26641

N/A

0DataRank · unranked

94 citations

Haiyan Liu, Cristina D. Toedebusch, David Freund, Tiara Redrick, Samir L. Chahin +6 more

Acute sleep loss decreases CSF‐to‐blood clearance of Alzheimer's disease biomarkers

Alzheimer s & Dementia(2023)10.1002/alz.12930

N/A

0DataRank · unranked

77 citations

Nicolas R. Barthélemy, Vitaliy Ovod, James G. Bollinger, Yingxin He, Samir L. Chahin +4 more

Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study

eLife(2023)10.7554/elife.81869

N/A

0DataRank · unranked

73 citations

Brian A. Gordon, Patrick H. Luckett, Tammie L.S. Benzinger, Carlos Cruchaga, Anne M. Fagan +13 more

Human striatal glia differentially contribute to AD- and PD-specific neurodegeneration

Nature Aging(2023)10.1038/s43587-023-00363-8

N/A

0DataRank · unranked

39 citations

Huifangjie L. Farsad, Yiran Hou, Kia M. Barclay, Ben Anthony Lopez, Shinnosuke Yamada +12 more

Brain network decoupling with increased serum neurofilament and reduced cognitive function in Alzheimer’s disease

Brain(2023)10.1093/brain/awac498

N/A

0DataRank · unranked

30 citations

Jeremy F. Strain, Patricia K. Mansfield, Jiaxin Cindy Tu, Aaron Tanenbaum, Oliver Preische +85 more

Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40

Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring(2023)10.1002/dad2.12405

N/A

0DataRank · unranked

30 citations

Brian A. Gordon, Anna H. Boerwinkle, Patrick H. Luckett, James G. Bollinger, Vitaliy Ovod +12 more

Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer’s disease

Brain Communications(2023)10.1093/braincomms/fcad280

N/A

0DataRank · unranked

20 citations

Leonardo Iaccarino, Dean W. Coble, Lauren Edwards, Yán Li, Eric McDade +37 more

Protein kinetics of superoxide dismutase‐1 in familial and sporadic amyotrophic lateral sclerosis

Annals of Clinical and Translational Neurology(2023)10.1002/acn3.51784

N/A

0DataRank · unranked

17 citations

Margaret D. Ireland, Wade Self, James Bollinger, Jennifer Jockel‐Balsarotti, Hillary Hope Herzog +13 more

Advanced structural brain aging in preclinical autosomal dominant Alzheimer disease

Molecular Neurodegeneration(2023)10.1186/s13024-023-00688-3

N/A

0DataRank · unranked

12 citations

Brian A. Gordon, Julie K. Wisch, Stephanie A. Schultz, Tammie L.S. Benzinger, Carlos Cruchaga +29 more

Design and feasibility of an Alzheimer's disease blood test study in a diverse community‐based population

Alzheimer s & Dementia(2023)10.1002/alz.13125

N/A

0DataRank · unranked

8 citations

Yan Li, Suzanne E. Schindler, Daniel Yen, Siobhan Sutcliffe, Ganesh M. Babulal +4 more

Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study

Alzheimer s Research & Therapy(2023)10.1186/s13195-023-01234-5

N/A

0DataRank · unranked

13 citations

David M. Cash, Teresa Poole, Paweł Markiewicz, Maggie R Fraser, Ian B. Malone +11 more

Chronic GCPII (glutamate‐carboxypeptidase‐II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques

Alzheimer s & Dementia Translational Research & Clinical Interventions(2023)10.1002/trc2.12431

N/A

0DataRank · unranked

12 citations

Dibyadeep Datta, Feng Liang, Nicolas R. Barthélemy, Robyn Wiseman, Barbara S. Slusher +13 more

Cross‐sectional and longitudinal comparisons of biomarkers and cognition among asymptomatic middle‐aged individuals with a parental history of either autosomal dominant or late‐onset Alzheimer's disease

Alzheimer s & Dementia(2023)10.1002/alz.12912

N/A

0DataRank · unranked

7 citations

Lena McCue, Virginia Buckles, Elizabeth Grant, Folasade Agboola, Dean W. Coble +17 more

Endogenous recapitulation of Alzheimer’s disease neuropathology through human 3D direct neuronal reprogramming

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.24.542155

N/A

0DataRank · unranked

10 citations

Ji‐Sun Kwon, Yudong Ren, Shawei Chen, K. Lynn Cates, Xinguo Lu +16 more

Design and feasibility of an Alzheimer’s disease blood test study in a diverse community-based population

medRxiv(2023)10.1101/2023.01.31.23285249

N/A

0DataRank · unranked

0 citations

Yan Li, Suzanne E. Schindler, Daniel Yen, Siobhan Sutcliffe, Ganesh M. Babulal +4 more

Clinical validation of the PrecivityAD2 blood test: A mass spectrometry‐based test with algorithm combining %p‐tau217 and Aβ42/40 ratio to identify presence of brain amyloid

Alzheimer s & Dementia(2024)10.1002/alz.13764

N/A

0DataRank · unranked

112 citations

Kristopher M. Kirmess, Stephanie Eastwood, Traci L. Wente‐Roth, Faith Irvin, Mary S. Holubasch +20 more

A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests

Brain(2024)10.1093/brain/awae346

N/A

0DataRank · unranked

102 citations

Gemma Salvadó, Shorena Janelidze, Niklas Mattsson, Divya Bali, Anna Orduña Dolado +19 more

Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset

Annals of Neurology(2024)10.1002/ana.26891

N/A

0DataRank · unranked

88 citations

Daniel Yen, Rachel Hendrix, Brian A. Gordon, Sibonginkhosi L. Dlamini, Nicolas R. Barthélemy +17 more

Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming

Science(2024)10.1126/science.adl2992

N/A

0DataRank · unranked

64 citations

Ji‐Sun Kwon, Yudong Ren, Shawei Chen, Courtney K. Walker, Xinguo Lu +16 more

CSF proteomics identifies early changes in autosomal dominant Alzheimer’s disease

Cell(2024)10.1016/j.cell.2024.08.049

N/A

0DataRank · unranked

61 citations

Jigyasha Timsina, Gyujin Heo, Aleksandra Beric, Muhammad Ali, Ciyang Wang +88 more

Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study

The Lancet Neurology(2024)10.1016/s1474-4422(24)00084-x

N/A

0DataRank · unranked

36 citations

Nicole S. McKay, Anna H. Boerwinkle, James L. Kennedy, Shaney Flores, Benjamin L. Handen +86 more

γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)

The Lancet Neurology(2024)10.1016/s1474-4422(24)00236-9

N/A

0DataRank · unranked

33 citations

Lei Liu, Aaron P. Schultz, Colleen Fitzpatrick, Raina Levin, Jean‐Pierre Bellier +94 more

Benchmarking of a multi‐biomarker low‐volume panel for Alzheimer's disease and related dementia research

Alzheimer s & Dementia(2024)10.1002/alz.14413

N/A

0DataRank · unranked

32 citations

Menghan Liu, Aleksandra Beric, Jigyasha Timsina, Pat Kohlfeld, Kristy Bergmann +17 more

Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer’s disease

Med(2024)10.1016/j.medj.2024.08.004

N/A

0DataRank · unranked

31 citations

Min Cho, Pallavi Sachdev, Jeffrey L. Dage, Suzanne Hendrix, Oskar Hansson +3 more

AmyloidPETNet: Classification of Amyloid Positivity in Brain PET Imaging Using End-to-End Deep Learning

Radiology(2024)10.1148/radiol.231442

N/A

0DataRank · unranked

30 citations

Maria Rosana Ponisio, Pan Xiao, Sung Min Ha, Satrajit Chakrabarty, John J. Lee +13 more

The case for regulatory approval of amyloid‐lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence

Alzheimer s & Dementia(2024)10.1002/alz.14342

N/A

0DataRank · unranked

29 citations

Randall J. Bateman, Damian C. Crowther, Jeff Cummings, John Dwyer, Takeshi Iwatsubo +7 more

Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease

Nature Communications(2024)10.1038/s41467-024-52937-8

N/A

0DataRank · unranked

28 citations

Lisa M. Häsler, Marius Lambert, Stephan A. Kaeser, Susanne Gräber‐Sultan, Ulrike Obermüller +88 more

Statistical considerations when estimating time‐saving treatment effects in Alzheimer's disease clinical trials

Alzheimer s & Dementia(2024)10.1002/alz.14035

N/A

0DataRank · unranked

24 citations

Gary Cutter, Neil P. Oxtoby, Guogen Shan, Whedy Wang, Brian Mangal +9 more

Baseline levels and longitudinal changes in plasma Aβ42/40 among Black and white individuals

Nature Communications(2024)10.1038/s41467-024-49859-w

N/A

0DataRank · unranked

20 citations

Jingqin Luo, David A. Wolk, Leslie M. Shaw, Erik D. Roberson, Charles Murchison +16 more

Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer’s disease

Brain Communications(2024)10.1093/braincomms/fcae081

N/A

0DataRank · unranked

23 citations

Patrick H. Luckett, Nicolas R. Barthélemy, Diana A. Hobbs, Charles D. Chen, James Bollinger +17 more

Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force

The Journal of Prevention of Alzheimer s Disease(2024)10.14283/jpad.2024.112

N/A

0DataRank · unranked

18 citations

J Cummings, C.J. Lansdall, Lavinia P. Middleton, Cristina Sampaio, S. Gauthier +95 more

Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease

Alzheimer s & Dementia(2024)10.1002/alz.13735

N/A

0DataRank · unranked

13 citations

Yan Li, Johannes Levin, Tammie L.S. Benzinger, Brian A. Gordon, Jason Hassenstab +20 more

Multi-peptide characterization of plasma neurofilament light chain in preclinical and mild Alzheimer’s disease

Brain Communications(2024)10.1093/braincomms/fcae247

N/A

0DataRank · unranked

13 citations

Yingxin He, Nicolas R. Barthélemy, Hong Jiang, David M. Holtzman, Randall J. Bateman +1 more

An interpretable machine learning‐based cerebrospinal fluid proteomics clock for predicting age reveals novel insights into brain aging

Aging Cell(2024)10.1111/acel.14230

N/A

0DataRank · unranked

12 citations

Yun Ju Sung, Miranda E. Orr, Andrew S. Yoo, Suzanne E. Schindler, Carlos Cruchaga +2 more

Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging

EBioMedicine(2024)10.1016/j.ebiom.2024.105080

N/A

0DataRank · unranked

11 citations

Austin McCullough, Brian A. Gordon, Charles D. Chen, Nicole S. McKay, Diana A. Hobbs +86 more

Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer’s disease

Brain Communications(2024)10.1093/braincomms/fcae159

N/A

0DataRank · unranked

10 citations

Jorge J. Llibre‐Guerra, Eric McDade, Lauren Edwards, Brian A. Gordon, Tammie L.S. Benzinger +32 more

Novel non‐linear models for clinical trial analysis with longitudinal data: A tutorial using SAS for both frequentist and Bayesian methods

Statistics in Medicine(2024)10.1002/sim.10089

N/A

0DataRank · unranked

10 citations

Whedy Wang, Brian Mangal, Yijie Liao, Lon S. Schneider, Yan Li +6 more

Predicting continuous amyloid PET values with CSF tau phosphorylation occupancies

Alzheimer s & Dementia(2024)10.1002/alz.14132

N/A

0DataRank · unranked

8 citations

Brian A. Gordon, Nicolas R. Barthélemy, Kanta Horie, Rachel L. Henson, Yingxin He +7 more

Unlocking Cognitive Analysis Potential in Alzheimer's Disease Clinical Trials: Investigating Hierarchical Linear Models for Analyzing Novel Measurement Burst Design Data

Statistics in Medicine(2024)10.1002/sim.10292

N/A

0DataRank · unranked

7 citations

Jason Hassenstab, Yan Li, Andrew J. Aschenbrenner, Eric McDade, Jorge J. Llibre‐Guerra +3 more

Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients

Annals of Neurology(2024)10.1002/ana.27027

N/A

0DataRank · unranked

7 citations

Suzanne E. Schindler, Amber Salter, Dana C. Perantie, Nicole Shelley, Bradley Judge +14 more

A genetic and proteomic comparison of key AD biomarkers across tissues

Alzheimer s & Dementia(2024)10.1002/alz.14139

N/A

0DataRank · unranked

5 citations

Daniel Western, Jigyasha Timsina, Priyanka Gorijala, Chengran Yang, Pau Pástor +8 more

Association of Resilience-Related Life Experiences on Variability on Age of Onset in Dominantly Inherited Alzheimer Disease

Neurology(2024)10.1212/wnl.0000000000209766

N/A

0DataRank · unranked

2 citations

Jae Seung Kim, Randall J. Bateman, Seon‐Ok Kim, Jorge J. Llibre‐Guerra, Gregory S. Day +15 more

Axonal damage and inflammation response are biological correlates of decline in small-world values: a cohort study in autosomal dominant Alzheimer’s disease

Brain Communications(2024)10.1093/braincomms/fcae357

N/A

0DataRank · unranked

3 citations

Courtney L. Sutphen, Ellen Dicks, Diederick M de Leeuw, Ricardo Allegri, Sarah Berman +33 more

Benchmarking of a multi-biomarker low-volume panel for Alzheimer’s Disease and related dementia research

medRxiv(2024)10.1101/2024.06.13.24308895

N/A

0DataRank · unranked

12 citations

Menghan Liu, Aleksandra Beric, Jigyasha Timsina, Pat Kholfeld, Kristy Bergmann +17 more

Systematic proteomics in Autosomal dominant Alzheimer’s disease reveals decades-early changes of CSF proteins in neuronal death, and immune pathways

medRxiv(2024)10.1101/2024.01.12.24301242

N/A

0DataRank · unranked

11 citations

Muhammad Ali, Jigyasha Timsina, Ciyang Wang, Anh Do, Daniel Western +32 more

Baseline levels and longitudinal rates of change in plasma Aβ42/40 among self-identified Black/African American and White individuals

Research Square(2024)10.21203/rs.3.rs-3783571/v1

N/A

0DataRank · unranked

10 citations

Suzanne E. Schindler, Jingqin Luo, John C. Morris, Randall J. Bateman, David M. Holtzman +16 more

The CentiMarker Project: Standardizing Quantitative Alzheimer’s disease Fluid Biomarkers for Biologic Interpretation

medRxiv(2024)10.1101/2024.07.25.24311002

N/A

0DataRank · unranked

2 citations

Yan Li, Johannes Levin, Yuchen Cao, Suzanne E. Schindler, Eric McDade +13 more

Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer’s disease

Nature Medicine(2025)10.1038/s41591-025-03617-7

N/A

0DataRank · unranked

99 citations

Gemma Salvadó, Rama K. Koppisetti, Shorena Janelidze, Nicolas R. Barthélemy, Yingxin He +14 more

Depressive Symptoms and Amyloid Pathology

JAMA Psychiatry(2025)10.1001/jamapsychiatry.2024.4305

N/A

0DataRank · unranked

20 citations

Julie Elisabeth Oomens, Sebastiaan Engelborghs, Chris Baeken, Christine A. F. Von Arnim, Mercè Boada +95 more

Integrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer’s disease

Alzheimer s Research & Therapy(2025)10.1186/s13195-024-01659-6

N/A

0DataRank · unranked

14 citations

Andrew B. Caldwell, Qing Liu, Michael Q. Fitzgerald, Srinivasan Ramachandran, Celeste M. Karch +95 more

Towards pharmacological prevention of Alzheimer disease

Nature Reviews Neurology(2025)10.1038/s41582-025-01154-y

N/A

0DataRank · unranked

9 citations

Eric McDade, Suzanne E. Schindler, David B. Clifford, Charlene Supnet, Alireza Atri +2 more

Ubiquitin–proteasome system in the different stages of dominantly inherited Alzheimer's disease

Alzheimer s & Dementia(2025)10.1002/alz.70243

N/A

0DataRank · unranked

9 citations

Quoc Bui, Jason Hassenstab, Brian A. Gordon, Tammie L.S. Benzinger, Jigyasha Timsina +32 more

The CentiMarker project: Standardizing quantitative Alzheimer's disease fluid biomarkers for biologic interpretation

Alzheimer s & Dementia(2025)10.1002/alz.14587

N/A

0DataRank · unranked

6 citations

Yan Li, Chengjie Xiong, Yuchen Cao, Suzanne E. Schindler, Eric McDade +13 more

Association of plasma Alzheimer's disease biomarkers with cognitive decline in cognitively unimpaired individuals

Alzheimer s & Dementia(2025)10.1002/alz.70625

N/A

0DataRank · unranked

6 citations

Heather J. Wiste, Terry M. Therneau, Michael Griswold, Niklas Mattsson, Sebastian Palmqvist +20 more

Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease

Acta Neuropathologica(2025)10.1007/s00401-025-02890-7

N/A

0DataRank · unranked

5 citations

Erin Franklin, Yan Li, Nelly Joseph‐Mathurin, Aime Burns, Diana A. Hobbs +93 more

Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN‐TU‐001 trial

Alzheimer s & Dementia(2025)10.1002/alz.70347

N/A

0DataRank · unranked

4 citations

Charles D. Chen, Brian A. Gordon, Nelly Joseph‐Mathurin, Clifford R. Jack, Robert Koeppe +47 more

Clinical progression on CDR‐SB©: Progression‐free time at each 0.5 unit level in dominantly inherited and sporadic Alzheimer's disease populations

Alzheimer s & Dementia(2025)10.1002/alz.70643

N/A

0DataRank · unranked

1 citations

Yan Li, Eric McDade, Chengjie Xiong, Sarah M. Hartz, Randall J. Bateman +4 more

Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers

Brain(2025)10.1093/brain/awaf375

N/A

0DataRank · unranked

1 citations

Shorena Janelidze, Nicolas R Barthélemy, Kanta Horie, Joseph Therriault, Lorenzo Gaetani +23 more

Kosmos: An AI Scientist for Autonomous Discovery

arXiv (Cornell University)(2025)10.48550/arxiv.2511.02824

N/A

0DataRank · unranked

11 citations

Angela Yiu, Benjamin Chang, Mathieu Bourdenx, Tyler Nadolski, Arvis Sulovari +32 more

Harnessing Greater Statistical Power: Comprehensive Evaluation of Disease Modifying Treatment Effects Across All or Multiple Post-Baseline Visits Compared to the Last Visit for Alzheimer’s Disease Clinical Trials

medRxiv(2025)10.1101/2025.02.18.25322498

N/A

0DataRank · unranked

1 citations

Tianle Chen, John O’Gorman, Yan Li, Caiyan Li, Leonard Guizzetti +7 more

Clinical Progression on CDR-SB © : Progression Free Time at Each 0.5-unit Level in Dominantly Inherited and Sporadic Alzheimer’s Disease Populations

medRxiv(2025)10.1101/2025.02.17.25322322

N/A

0DataRank · unranked

0 citations

Yan Li, Eric McDade, Chengjie Xiong, Sarah M. Hartz, Randall J. Bateman +3 more

Remote Digital Cognitive Assessment in a Trial-Ready Alzheimer’s Cohort: A Scalable Approach for Early Intervention Studies

(2025)10.31234/osf.io/mz62t_v1

N/A

0DataRank · unranked

0 citations

Hannah Wilks, Matthew S. Welhaf, Samhita Katteri, Sarah H. Stout, Martin J. Sliwinski +19 more

CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer’s disease

Brain(2020)10.1093/brain/awaa373

N/A

0DataRank · unranked

188 citations

Nicolas R. Barthélemy, Chihiro Sato, Randall J. Bateman, Kanta Horie

Associations of lifestyle factors with amyloid pathology in persons without dementia

Journal of Alzheimer s Disease(2025)10.1177/13872877251379083

N/A

0DataRank · unranked

0 citations

Stephanie J. B. Vos, Nancy N. Maserejian, Mercè Boada, Mira Didic, Sebastiaan Engelborghs +95 more

Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease

The Journal of Experimental Medicine(2020)10.1084/jem.20200861

N/A

0DataRank · unranked

439 citations

Kanta Horie, Chihiro Sato, Randall J. Bateman, Nicolas R. Barthélemy

Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification

Alzheimer s Research & Therapy(2020)10.1186/s13195-020-00596-4

N/A

0DataRank · unranked

256 citations

Randall J. Bateman, Christophe Hirtz, Philippe Marin, François Bécher, Chihiro Sato +3 more

Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease‐informed machine‐learning

Alzheimer s & Dementia(2020)10.1002/alz.12032

N/A

0DataRank · unranked

76 citations

Nikolaos Koutsouleris, Tammie L.S. Benzinger, Alison Goate, Celeste M. Karch, Anne M. Fagan +21 more

Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease

Neurobiology of Disease(2020)10.1016/j.nbd.2020.104960

N/A

0DataRank · unranked

60 citations

Jeremy F. Strain, Adedamola Adedokun, Qing Wang, Oliver Preische, Jens Kühle +41 more

Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer’s disease

Brain Communications(2020)10.1093/braincomms/fcaa102

N/A

0DataRank · unranked

21 citations

Ellen Dicks, Guoqiao Wang, Aylin Dincer, Shaney Flores, Sarah Keefe +81 more

Ante‐ and postmortem tau in autosomal dominant and late‐onset Alzheimer’s disease

Annals of Clinical and Translational Neurology(2020)10.1002/acn3.51237

N/A

0DataRank · unranked

18 citations

Timothy R. Holden, Brian A. Gordon, Erin Franklin, Yan Li, Dean W. Coble +9 more

Microglia Implicated in Tauopathy in the Striatum of Neurodegenerative Disease Patients from Genotype to Phenotype

International Journal of Molecular Sciences(2020)10.3390/ijms21176047

N/A

0DataRank · unranked

10 citations

William C. Knight, Pengfei Yang, Yingqiu Guo, Joel S. Perlmutter, John C. Morris +4 more

Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease

NeuroImage Clinical(2020)10.1016/j.nicl.2020.102491

N/A

0DataRank · unranked

35 citations

Brian A. Gordon, Amrita Hari‐Raj, Sarah Keefe, Shaney Flores, Nicole S. McKay +37 more

Item response theory analysis of the Clinical Dementia Rating

Alzheimer s & Dementia(2020)10.1002/alz.12210

N/A

0DataRank · unranked

34 citations

Johannes Levin, Andrew J. Aschenbrenner, Chih‐Hung Chang, Michael W. Weiner, Rachel L. Nosheny +6 more

Relationships between big‐five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease

Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring(2020)10.1002/dad2.12038

N/A

0DataRank · unranked

27 citations

Jennifer Petros, Eric McDade, Guoqiao Wang, David A. Balota, Tammie L.S. Benzinger +18 more

Presymptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy-Related Blood Metabolite Alterations

Journal of Alzheimer s Disease(2020)10.3233/jad-201267

N/A

0DataRank · unranked

8 citations

Dominantly Inherited Alzheimer Network, Anne M. Fagan, Chengjie Xiong, Matthew J. McKay, Atul Bhatnagar +18 more

Functional brain age prediction suggests accelerated aging in preclinical familial Alzheimer’s disease, irrespective of fibrillar amyloid-beta pathology

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.06.076745

N/A

0DataRank · unranked

6 citations

Alex T. Baria, Alexa Pichet Binette, Brian A. Gordon, Jasmeer P. Chhatwal, Carlos Cruchaga +15 more

A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease

Nature Medicine(2021)10.1038/s41591-021-01369-8

N/A

0DataRank · unranked

365 citations

Martin R. Farlow, Eric McDade, David B. Clifford, Guoqiao Wang, Jorge J. Llibre‐Guerra +61 more

A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis

Molecular Neurodegeneration(2021)10.1186/s13024-021-00451-6

N/A

0DataRank · unranked

233 citations

Kristopher M. Kirmess, Matthew R. Meyer, Mary S. Holubasch, S Knapik, Yan Hu +10 more

Segregation of functional networks is associated with cognitive resilience in Alzheimer’s disease

Brain(2021)10.1093/brain/awab112

N/A

0DataRank · unranked

146 citations

Ying Luan, Lukas Frontzkowski, Julia Neitzel, Anna Rubinski, Martin Dichgans +35 more

The informed road map to prevention of Alzheimer Disease: A call to arms

Molecular Neurodegeneration(2021)10.1186/s13024-021-00467-y

N/A

0DataRank · unranked

111 citations

Jorge J. Llibre‐Guerra, David M. Holtzman, John C. Morris, Randall J. Bateman, Eric McDade

Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease

Nature Communications(2021)10.1038/s41467-021-25492-9

N/A

0DataRank · unranked

103 citations

Alex T. Baria, Alexa Pichet Binette, Brian A. Gordon, Jasmeer P. Chhatwal, Carlos Cruchaga +94 more

Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET

Neurology(2021)10.1212/wnl.0000000000012775

N/A

0DataRank · unranked

96 citations

Yan Li, Virginia D. Buckles, Brian A. Gordon, Tammie L.S. Benzinger, Guoqiao Wang +8 more

Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study

The Lancet Neurology(2021)10.1016/s1474-4422(21)00139-3

N/A

0DataRank · unranked

71 citations

Rachel L. Henson, Yan Li, Anna H. Boerwinkle, Chengjie Xiong, Randall J. Bateman +29 more

The global Alzheimer's Association round robin study on plasma amyloid β methods

Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring(2021)10.1002/dad2.12242

N/A

0DataRank · unranked

45 citations

Leslie M. Shaw, Magdalena Korecka, Teresa Waligórska, Charlotte E. Teunissen, Erik Stoops +30 more

Astrocytic 4R tau expression drives astrocyte reactivity and dysfunction

JCI Insight(2021)10.1172/jci.insight.152012

N/A

0DataRank · unranked

43 citations

Kathleen M. Schoch, Chihiro Sato, Mariana Beltcheva, Kanta Horie, Frank Rigo +5 more

Does Data-Independent Acquisition Data Contain Hidden Gems? A Case Study Related to Alzheimer’s Disease

Journal of Proteome Research(2021)10.1021/acs.jproteome.1c00558

N/A

0DataRank · unranked

37 citations

Lilian R. Heil, Gennifer E. Merrihew, Jasmeer P. Chhatwal, Martin R. Farlow, Catriona McLean +11 more

Plasma Amyloid-Beta Levels in a Pre-Symptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy Pedigree: A Cross-Sectional and Longitudinal Investigation

International Journal of Molecular Sciences(2021)10.3390/ijms22062931

N/A

0DataRank · unranked

24 citations

Michelle Tegg, Steve Pedrini, Anne M. Fagan, Chengjie Xiong, Abhay Kumar Singh +19 more

Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease

Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring(2021)10.1002/dad2.12197

N/A

0DataRank · unranked

22 citations

Adam M. Staffaroni, John M. Ringman, Yann Cobigo, Sheng‐Yang M. Goh, Amy Wolf +38 more

MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology

Annals of Clinical and Translational Neurology(2021)10.1002/acn3.51435

N/A

0DataRank · unranked

20 citations

Nipun Mallipeddi, Nupur Ghoshal, Brenton A. Wright, Gregory S. Day, Albert A. Davis +6 more

Modeling autosomal dominant Alzheimer's disease with machine learning

Alzheimer s & Dementia(2021)10.1002/alz.12259

N/A

0DataRank · unranked

15 citations

Austin McCullough, Brian A. Gordon, Jeremy F. Strain, Shaney Flores, Aylin Dincer +46 more

Randall J. Bateman

Indexed papers

Top data-sharing exemplar

Papers